BVSbenzinga

Bioventus Agrees To Nationwide Contract With Cigna Commercial Plans For DUROLANE And GELSYN-3 For Knee Osteoarthritis; No Terms Disclosed

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 2, 2022 by benzinga

Last updated: August 6, 2025 at 09:44 PM

    Bioventus Agrees To Nationwide Contract With Cigna Commercial Plans For DUROLANE And GELSYN-3 For Knee Osteoarthritis; No Terms Disclosed | BVS Stock News | Candlesense